Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
724studies shown
Showing 151-175 of 724
RecruitingNCT05656469

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

AnxietyOtherFrom 16 Years to 65 Years
Countries
Germany, Netherlands, Romania, Serbia, Spain, United Kingdom, United States
Sponsor
Maastricht University Medical Center
Condition
Anxiety
RecruitingNCT05185128

Neural Basis of Social Cognition Deficits

This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.

SchizophreniaOtherFrom 12 Years to 18 Years
Countries
United States
Sponsor
Loma Linda University
Condition
Schizophrenia
RecruitingNCT06672588

Magnetic Seizure Therapy for Schizophrenia - Trial

This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07383324

Heat Stress in Individuals With Schizophrenia

This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Schizophrenia
RecruitingNCT06456983

Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

This study is looking at whether maintenance electroconvulsive therapy (mECT) can help people with Schizophrenia or Treatment Resistant Schizophrenia. Participants take part in maintenance electroconvulsive therapy (mECT) and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
RecruitingNCT07177261

Inter-Brain Synchrony in Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingNCT07378150

Clay Therapy in Schizophrenia Patients

This study is looking at whether Clay therapy can help people with Schizophrenia and Related Disorders. Participants take part in Clay therapy and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
Turkey
Sponsor
Kutahya Health Sciences University
Condition
Schizophrenia
RecruitingNCT03995121

SV2 PET Imaging With [11C]APP311

This observational study is following people with Schizophrenia and Other psychosis, Cannabis Use Disorder, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
RecruitingNCT06568081

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

This observational study is looking at how a digital support tool works for people with Schizophrenia Spectrum and Other psychosis or Affective Psychoses in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
RecruitingNCT05208190

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

This observational study is following people with Schizophrenia or schizoaffective disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
RecruitingNCT04370730

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 7 Years to 20 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
RecruitingNCT05316883

Biomarkers in Clozapine-responding Schizophrenia

This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Denmark
Sponsor
Jimmi Nielsen
Condition
Schizophrenia
RecruitingNCT07343193

Deprescribing Antipsychotics: a Multiple Case Study

This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
RecruitingNCT06961968

Randomized Withdrawal Study in Patients With Schizophrenia

This study is comparing iloperidone with placebo for people with Schizophrenia. Participants receive iloperidone or placebo and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research